SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12798886
Source:
http://linkedlifedata.com/resource/pubmed/id/12798886
Search
Subject
(
62
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008976
,
umls-concept:C0020699
,
umls-concept:C0030705
,
umls-concept:C0034656
,
umls-concept:C0042133
,
umls-concept:C0120107
,
umls-concept:C0279752
,
umls-concept:C0935916
pubmed:issue
6
pubmed:dateCreated
2003-6-11
pubmed:abstractText
To compare the use of a new antiestrogen fulvestrant with goserelin in reducing uterine fibroid growth before hysterectomy.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0372772
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Estradiol
,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Receptor Modulators
,
http://linkedlifedata.com/resource/pubmed/chemical/Goserelin
,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen
,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone
,
http://linkedlifedata.com/resource/pubmed/chemical/fulvestrant
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0015-0282
pubmed:author
pubmed-author:AudebertAlainA
,
pubmed-author:DonnezJacquesJ
,
pubmed-author:Hervais VivancosBlasB
,
pubmed-author:JadoulPascaleP
,
pubmed-author:KudelaMilanM
pubmed:issnType
Print
pubmed:volume
79
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1380-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12798886-Adult
,
pubmed-meshheading:12798886-Biopsy
,
pubmed-meshheading:12798886-Bone Resorption
,
pubmed-meshheading:12798886-Endometrium
,
pubmed-meshheading:12798886-Estradiol
,
pubmed-meshheading:12798886-Estrogen Antagonists
,
pubmed-meshheading:12798886-Estrogen Receptor Modulators
,
pubmed-meshheading:12798886-Female
,
pubmed-meshheading:12798886-Goserelin
,
pubmed-meshheading:12798886-Humans
,
pubmed-meshheading:12798886-Hysterectomy
,
pubmed-meshheading:12798886-Leiomyoma
,
pubmed-meshheading:12798886-Middle Aged
,
pubmed-meshheading:12798886-Premenopause
,
pubmed-meshheading:12798886-Receptors, Estrogen
,
pubmed-meshheading:12798886-Receptors, Progesterone
,
pubmed-meshheading:12798886-Uterine Neoplasms
pubmed:year
2003
pubmed:articleTitle
A randomized, placebo-controlled, dose-ranging trial comparing fulvestrant with goserelin in premenopausal patients with uterine fibroids awaiting hysterectomy.
pubmed:affiliation
Catholic University of Louvain, Brussels, Belgium. donnez@gyne.ucl.ac.be
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study